Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study

被引:76
|
作者
Pulignano, Giovanni [1 ]
Del Sindaco, Donatella [2 ]
Di Lenarda, Andrea [3 ]
Tarantini, Luigi [4 ]
Cioffi, Giovanni [5 ]
Gregori, Dario [6 ]
Tinti, Maria Denitza [1 ]
Monzo, Luca [1 ]
Minardi, Giovanni [1 ]
机构
[1] San Camillo Hosp, Heart Failure Clin, Div Cardiol, Coronary Care Unit, Trieste, Italy
[2] Inst Care & Res Elderly INRCA, Heart Failure Unit, Div Cardiol, Trieste, Italy
[3] Cardiovasc Ctr & Univ, Trieste, Italy
[4] San Martino Hosp, Heart Failure Clin, Div Cardiol, Belluno, Italy
[5] Villa Bianca Hosp, Heart Failure Clin, Div Cardiol, Trento, Italy
[6] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy
关键词
cost-effectiveness; elderly; frailty; heart failure; management programs; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; CARE; MULTIDISCIPLINARY; PREVENT; INTERVENTION; CARDIOLOGY; MORTALITY; ADMISSION; OUTCOMES;
D O I
10.2459/JCM.0b013e328339d981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Disease management programs (DMP) improve outcomes in patients with heart failure. Because older heart failure patients represent a heterogeneous population, the aim of this study was to determine which patients benefit mostly from a DMP, by means of their frailty profile. Setting Heart failure outpatient clinic. Methods Consecutive (n = 173) patients aged more than 70 years were randomized to a multidisciplinary DMP (n = 86) or usual care (n = 87). A modified frailty score (range 1-6) was used as an index of global functional impairment. Results Mild to moderate frailty (frailty score = 2-3) was associated with significant improvements in outcomes (death and/or heart failure admission, heart failure admissions and all-cause admissions) in DMP patients vs. usual care. Even in more frail patients (frailty score = 4-6) a significant reduction in heart failure admissions was observed. By contrast, nonfrail patients (frailty score = 1) did not derive significant benefit. In the cost-effectiveness analysis, the mean savings per patient, stratified according to their frailty score, were (sic) -1003.31 for frailty score 1 (95% confidence interval -3717.00-1709.00), (sic) 1104.72 for frailty score 2 (-280.6-2491.00), (sic) 2635.42 for frailty score 3 (352.60-4917.00, P = 0.025) and (sic) 419.53 for frailty score 4-6 (-1909.00-2749.00). Intervention was therefore significantly cost saving in moderately frail, but not in nonfrail or severely frail patients. Thus, DMP was dominant (i.e. both less costly and more effective than usual care) in moderately frail patients. At sensitivity analysis, DMP remained dominant even to changes in cost of intervention and hospitalizations. Conclusion This suggests that an intensive, hospital-based DMP appears to be more effective in older patients with mild-to-moderate levels of frailty. Thus, a multidimensional assessment of frailty seems to be a useful tool for appropriate selection of model of care. J Cardiovasc Med 11: 739-747 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:739 / 747
页数:9
相关论文
共 50 条
  • [41] Cost-Effectiveness Considerations in Transcatheter Management of Valvular Heart Disease
    Gadey, Gautam
    Reynolds, Matthew R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (09) : 1058 - 1063
  • [42] Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
    Simon Lebech Cichosz
    Lars Holger Ehlers
    Ole Hejlesen
    Trials, 17
  • [43] Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
    Cichosz, Simon Lebech
    Ehlers, Lars Holger
    Hejlesen, Ole
    TRIALS, 2016, 17
  • [44] Assessment of frailty and related outcomes in older patients with heart failure: A cohort study
    Tournas, Georgios
    Kourek, Christos
    Mantzaraki, Vassiliki
    Georgiopoulos, Georgios
    Pantos, Constantinos
    Toumanidis, Savvas
    Briasoulis, Alexandros
    Paraskevaidis, Ioannis
    HELLENIC JOURNAL OF CARDIOLOGY, 2022, 67 : 42 - 47
  • [45] Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial
    Sydow, Hanna
    Prescher, Sandra
    Koehler, Friedrich
    Koehler, Kerstin
    Dorenkamp, Marc
    Spethmann, Sebastian
    Westerhoff, Benjamin
    Wagner, Christoph J.
    Liersch, Sebastian
    Rebscher, Herbert
    Wobbe-Ribinski, Stefanie
    Rindfleisch, Heike
    Mueller-Riemenschneider, Falk
    Willich, Stefan N.
    Reinhold, Thomas
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (11) : 1231 - 1244
  • [46] Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China
    Lou, Yake
    Hu, Tianyang
    Huang, Jing
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (01) : 47 - 57
  • [47] Cost-effectiveness of add-on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes
    Abushanab, Dina
    Chbib, Salma
    Kaddoura, Rasha
    Al Hail, Moza
    Rouf, Palli Valappila Abdul
    El Kassem, Wessam
    Shah, Jassim
    Nair, Ramesh Kumar Ravindran
    Al-Badriyeh, Daoud
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 404 - 417
  • [48] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [49] Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failure
    Gruson, D.
    Mancini, M.
    Ahn, S. A.
    Rousseau, M. F.
    CLINICAL BIOCHEMISTRY, 2014, 47 (12) : 1006 - 1009
  • [50] Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation
    Estler, Bent
    Rudolph, Volker
    Seleznova, Yana
    Shukri, Arim
    Stock, Stephanie
    Mueller, Dirk
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022,